Same Drug Class

Imatinib vs Rituximab

Imatinib vs Rituximab: Overview

This comparison examines the pharmacological differences between Imatinib and Rituximab.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Imatinib — 18 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Imatinib — C29H31N7O.

Molecular Weight: Imatinib — 493.6030 g/mol.

Type: Imatinib — Small molecule; Rituximab — Antibody.